AAAAAA
Results:
1-14
|
Results: 14
Authors:
Wexler, HM
Molitoris, E
Molitoris, D
Finegold, SM
Citation: Hm. Wexler et al., In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria, J ANTIMICRO, 47(4), 2001, pp. 467-469
Authors:
Wexler, HM
Molitoris, E
Molitoris, D
Finegold, SM
Citation: Hm. Wexler et al., In vitro activity of moxifloxacin against 179 strains of anaerobic bacteria found in pulmonary infections, ANAEROBE, 6(4), 2000, pp. 227-231
Authors:
Talan, DA
Summanen, PH
Finegold, SM
Citation: Da. Talan et al., Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and othersoft-tissue abscesses in patients with or without histories of injection drug abuse, CLIN INF D, 31(2), 2000, pp. 464-471
Authors:
Sandler, RH
Finegold, SM
Bolte, ER
Buchanan, CP
Maxwell, AP
Vaisanen, ML
Nelson, MN
Wexler, HM
Citation: Rh. Sandler et al., Short-term benefit from oral vancomycin treatment of regressive-onset autism, J CHILD NEU, 15(7), 2000, pp. 429-435
Authors:
Wexler, HM
Molitoris, D
Finegold, SM
Citation: Hm. Wexler et al., In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobicbacteria, ANTIM AG CH, 44(8), 2000, pp. 2222-2224
Authors:
Claros, MC
Schumacher, U
Jacob, M
Gerardo, SH
Kleinkauf, N
Goldstein, EJC
Finegold, SM
Rodloff, AC
Citation: Mc. Claros et al., Characterization of Bilophila wadsworthia isolates using PCR fingerprinting, ANAEROBE, 5(6), 1999, pp. 589-593
Authors:
Wexler, HM
Molitoris, E
Molitoris, D
Finegold, SM
Citation: Hm. Wexler et al., In vitro activity of HMR 3004 (RU 64004) against 502 strains of anaerobic bacteria, ANAEROBE, 5(2), 1999, pp. 65-68
Authors:
Summanen, PH
McTeague, M
Vaisanen, ML
Strong, CA
Finegold, SM
Citation: Ph. Summanen et al., Comparison of recovery of anaerobic bacteria using the Anoxomat (R), anaerobic chamber, and GasPak (R) jar systems, ANAEROBE, 5(1), 1999, pp. 5-9
Authors:
Finegold, SM
Citation: Sm. Finegold, Swan song, CLIN INF D, 29(6), 1999, pp. 1367-1368
Authors:
Finegold, SM
Citation: Sm. Finegold, Recollections of an early anaerobist, INF DIS C P, 8(3), 1999, pp. 147-150
Authors:
Finegold, SM
Citation: Sm. Finegold, In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections, INT J ANT A, 12, 1999, pp. S9-S14
Authors:
Matto, J
Asikainen, S
Vaisanen, ML
von Troil-Linden, B
Kononen, E
Saarela, M
Salminen, K
Finegold, SM
Jousimies-Somer, H
Citation: J. Matto et al., beta-lactamase production in Prevotella intermedia, Prevotella nigrescens,and Prevotella pallens genotypes and in vitro susceptibilities to selectedantimicrobial agents, ANTIM AG CH, 43(10), 1999, pp. 2383-2388
Authors:
Allo, MD
Bennion, RS
Kathir, K
Thompson, JE
Lentz, M
Meute, M
Finegold, SM
Citation: Md. Allo et al., Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis, AM SURG, 65(2), 1999, pp. 99-104
Authors:
Wexler, HM
Finegold, SM
Citation: Hm. Wexler et Sm. Finegold, Current susceptibility patterns of anaerobic bacteria, YONSEI MED, 39(6), 1998, pp. 495-501
Risultati:
1-14
|